Wenzel, M., Borkowetz, A., Lieb, V., Hoffmann, M. A., Borgmann, H., Höfner, T., . . . Klümper, N. (2022). Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in Germany : clinical bladder cancer. Urologic oncology, 40(12), . https://doi.org/10.1016/j.urolonc.2022.09.011
Chicago-Zitierstil (17. Ausg.)Wenzel, Mike, et al. "Efficacy of Cabazitaxel in Fourth or Later Line of Therapy in Metastatic Castration-resistant Prostate Cancer: Multi-institutional Real-world Experience in Germany : Clinical Bladder Cancer." Urologic Oncology 40, no. 12 (2022). https://doi.org/10.1016/j.urolonc.2022.09.011.
MLA-Zitierstil (9. Ausg.)Wenzel, Mike, et al. "Efficacy of Cabazitaxel in Fourth or Later Line of Therapy in Metastatic Castration-resistant Prostate Cancer: Multi-institutional Real-world Experience in Germany : Clinical Bladder Cancer." Urologic Oncology, vol. 40, no. 12, 2022, https://doi.org/10.1016/j.urolonc.2022.09.011.